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Abstract: Little is known about the impact of vaccine shortages on vaccination rates among 
disadvantaged populations in the United States. We compared factors associated with 
influenza vaccination rates during a vaccine shortage (2004–2005) and a non-shortage 
(2003–2004) year among adults in predominantly minority New York City neighborhoods. 
Thirty-one percent of participants received influenza vaccine during the non-shortage year 
compared with 18% during the shortage. While fewer people received the influenza vaccine 
during the shortage, a higher proportion of the vaccinated were in a high-risk group (68% 
vs. 52%, respectively). People were less likely to have been vaccinated during the shortage if 
they were Black. This study suggests that vaccination rates were lower during the shortage 
period among Blacks and those who are not explicitly a focus of national vaccination out-
reach campaigns. Such groups are less likely to be vaccinated when vaccines are scarce.
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On October 5, 2004, Chiron Corporation notified the Centers for Disease Control and Prevention (CDC) that none of its inactivated influenza vaccine would be 
available for distribution in the United States for the 2004–2005 influenza season. At 
that time, the CDC, in coordination with the Advisory Committee on Immunization 
Practices (ACIP), issued interim recommendations to direct available inactivated 
influenza vaccine to high-risk individuals.1 This was the second time in recent years 
that a delay in the distribution of influenza vaccine would result in a call for voluntary 
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rationing of the vaccine,2 a tactic that did not succeed during the influenza season of 
2000–2001. During that season, employers and others serving low-risk populations 
received vaccine while physicians serving primarily older and high-risk populations 
frequently did not.3 Therefore, during the 2004–2005 influenza season, we examined 
vaccination rates among residents of socioeconomically disadvantaged areas of New York 
City. We examined the factors associated with receipt of vaccine during the shortage 
among residents of these two communities in order to inform future efforts to direct 
scarce vaccine resources to members of high-risk populations.
Methods
The data presented in this study are a subset of the data collected from Project VIVA 
(Venue-Intensive Vaccines for Adults), a multi-level community-based participatory 
research (CBPR) intervention designed to immunize hard-to-reach (HTR) populations 
in low-income neighborhoods in East Harlem and the Bronx. There is no accepted 
definition of HTR populations; populations of interest for this project included sub-
stance abusers, sex workers, undocumented immigrants, people who are homeless, 
and homebound elderly.
The parent project was structured in 5 phases: The first phase (February–October 
2004) was an enumeration and survey of the target population, a detailed description 
of which has been previously published.4 Phase II, the focus of this paper, was a survey 
to examine access to vaccination during the national shortage (October–December 
2004). Phase III (January–March 2005) was the implementation of a pilot door-to-door 
influenza vaccination program. Using a cross-over design we randomly selected 4 of 
the 8 study neighborhoods to receive the pilot vaccination program initially. Then, in 
phase IV (September–October 2005), the remaining 4 neighborhoods received the 
vaccine program over a period of 10 days.5 The latter vaccination effort was used to 
test the feasibility of rapid vaccination of HTR populations in the event of an influenza 
pandemic or bioterrorist threat. The most promising elements of the project were dis-
seminated during the fifth and final phase of the project. 
The eight study neighborhoods were identified through consultation with community-
based organizations in the communities of East Harlem and the Bronx. Anestimated 
24,000 individuals reside in the neighborhoods (each roughly six to eight blocks in 
size).* Census data indicate that the neighborhoods are 31% Black and 65% Latino; 
* The neighborhoods in East Harlem are the following: 108th Street to 112th Street, between Lexington 
and Park Avenues, 109th Street to 111th Street, between Park and Madison (Eh1); 119th Street to 
125th Street, between 3rd and Lexington Avenues, 121st Street to 123rd Street, between Lexington 
and Park Avenues (Eh2); 116th Street to 117th Street, between 1st and Madison Avenues (Eh3). 
The neighborhoods in the Bronx are the following: 146th Street to 149th Street, between Brook and 
Willis/Bergen Avenues (BX4); the areas bounded by Simpson Street and Intervale Avenue on the east 
and west, Westchester Avenue to the north, and Beck/Fox Streets to the south (BX5); from Hunts 
Point Avenue to Longfellow Avenue, between Seneca and Garrison Avenues (BX6); Wheeler Avenue 
to Manor Avenue, between Bruckner Boulevard and Watson Avenue (BX7); 182nd Street to 183rd 
Street, between Jerome and Aqueduct Avenues, Cameron Place to 182nd Street, between Morris and 
Jerome Avenues (BX8).
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53% of residents are female. About half of residents have not completed high school, 
compared with 28% in New York City as a whole. Approximately 20% of people in 
these neighborhoods are unemployed, 68% have a total household income of $30,000 
a year or less, and 45% lived below the poverty level in 1999. The mean per capita 
income in the East Harlem neighborhoods is approximately $10,000; it is $8,000 in 
the Bronx neighborhoods (compared with an average of $23,000 for New York City).6 
These neighborhoods have some of the highest morbidity and mortality rates secondary 
to asthma, diabetes, heart disease, HIV, and substance abuse in the city.7 People were 
eligible for participation in the study if they were 18 years of age or older, spoke English 
or Spanish, and could provide informed consent. The Institutional Review Board of 
The New York Academy of Medicine approved all phases of the study. 
A brief in-person questionnaire was developed to assess: 1) sociodemographic 
characteristics, including age, gender, race, and education; 2) characteristics that may 
be associated with social marginalization, including substance abuse and commercial 
sex work; 3) access to health care; 4) vaccination history; 5) general health; and 6) 
trust in government and social agencies. In October 2004, at the onset of the vaccine 
shortage, questions were added to the questionnaire to examine: 1) perceptions of 
the shortage; 2) vaccine eligibility based on the CDC’s designated priority groups;* 3) 
impact of the shortage on participants’ present and future receipt of vaccinations and 
other health care services. 
Data were collected using a venue-based application of time-space sampling.8,9 
Time-space sampling seeks to recruit target populations in places and times where 
these populations can be reasonably expected to gather. Using extensive fieldwork, 
consultation with our collaborating community-based organizations, and prior outreach 
experience described elsewhere,10 we identified two street-based venue sites in each 
of the eight study neighborhoods that were routinely frequented by members of HTR 
populations (drug outreach centers and meeting places for undocumented immigrants 
to find off-the books employment). After constructing a sampling frame of venues and 
associated sampling periods (e.g., a bottle repository on 125th street between 1:00 pm 
and 4:00 pm) pairs of outreach workers systematically interviewed every willing adult 
that came through the venue. A brief, anonymous questionnaire was administered to all 
eligible participants who gave verbal consent. Venue-based sampling was conducted at 
the same venues in all eight of the study neighbourhoods from February through April 
of 2004, which represents the non-shortage vaccine period (to which we will refer as 
the non-shortage period) and from October–December 2004 (to which we will refer as 
the shortage period). In both phases, participants were provided street-side education 
on influenza prevention and, during the shortage period, weekly updates and informa-
tion about locations for eligible people to obtain influenza vaccine.
Sociodemographic characteristics of participants interviewed during the two vac-
cine seasons were compared and contrasted using the chi-square test for categorical 
* People designated as being priority groups for vaccination were people who 65 years of age and older, 
and adults who have heart disease, kidney disease, diabetes, HIV/AIDS, asthma, and other chronic 
conditions. Health care workers with direct patient contact, and caregivers of and household contact 
with infants under 6 months of age were also priority groups for vaccination. 
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variables and Student’s t test for continuous variables. Logistic regression analysis was 
used to assess factors associated with recent influenza vaccination. Recent influenza 
vaccination was defined as having been vaccinated since the fall of the previous year. 
Two multivariate models were constructed, one with non-shortage period data, and 
the other with shortage period data. The non-shortage period model was adjusted for 
age, history of homelessness, history of injection drug use, health insurance coverage, 
source of routine medical care, prior use of government, community health or social 
services, HIV status, and medical indication for the vaccine (e.g., people in CDC-
designated priority groups for vaccination). The shortage period model was adjusted 
for age, gender, racial/ethnic background, source of routine medical care, HIV status, 
and medical indication for the vaccine. A significance value of p.10 was chosen as 
a criterion for variable selection. We chose to include variables in the model that had 
borderline significant associations with the outcome so as to ensure that we adjusted 
for all potentially important variables, even those that did not meet the more usual 
p.05 cutoff. From the final model, odds ratios (ORs) and corresponding 95% confi-
dence intervals (CIs) were derived. All analyses were performed using SAS software, 
Version 8 of the SAS system for Windows (SAS Corp., Cary, NC).
results 
A total of 773 participants were interviewed during the non-shortage period and 272 
participants were interviewed during the shortage period. Surveys were excluded if any 
of the following variables were missing: age, gender, race/ethnicity, health insurance 
status, routine medical care, source of care, injection of illegal drugs, and presence of 
medical indications/ contraindications to influenza vaccine. One hundred and eighty-
two (24%) of the surveys were excluded from the analysis of the non-shortage period, 
and 62 (23%) were excluded from the shortage period analysis. The analyses presented 
here are limited to surveys without missing variables. The characteristics of 591 study 
participants from the non-shortage period and 210 participants from the shortage 
period are reported in Table 1. Participants included in this analysis did not differ sig-
nificantly from those excluded with respect to age, race/ethnicity, income, illicit drug 
use, receipt of routine medical care, HIV status, or indications for influenza vaccination. 
Respondents excluded from analysis in the non-shortage period were more likely than 
participants in the shortage period to be uninsured (p.06). In addition, respondents 
excluded from analysis in the shortage period were more likely than participants in 
the non-shortage period to be male (p.03). 
Participants in the shortage period were significantly younger in age than those in 
the non-shortage period (mean age 36 years vs. 39 years). There were more women 
(79% vs. 56%), more Blacks (25% vs. 17%), and higher household incomes (37% vs. 
26%) among participants in the shortage period than among those in the non-shortage 
period. Congruent with the higher reported income, participants in the shortage period 
had lower reports of previous homelessness (26% vs. 38%), hunger (12% vs. 28%), and 
lifetime injection drug use (8% vs. 13%). Concerning health care, more participants in 
the shortage period than in the non-shortage period received routine medical care (83% 
vs. 70%). Of those participants who had health insurance, shortage period participants 
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table 1. 
CharaCterIStICS of PartICIPaNtS INterVIewed  
IN the NoN-Shortage aNd Shortage PerIodSa
 Non-shortage Shortage period 
 (n591) (n210) 
Characteristics n % n % p-value
Age
18–39 308 52 133 63 .01
40–64 238 40 74 35 
65 45 8 3 1 
Gender 
Male 260 44 45 21 .01
Female 328 56 165 79 
Race/ethnicity 
Hispanic 449 76 142 68 .02
Black 98 17 53 25 
Caucasian/other 44 7 15 7 
Income 
$9,600/year or less 415 74 131 63 .01
$9,601/year or more 149 26 76 37 
History of homelessness 225 38 54 26 .01
Hungry in the past 6 months 165 28 26 12 .01
History of injection drug use 75 13 17 8 .07
History of illegal drug use 358 61 129 61 .83
History of trading sex 38 6 12 6 .70
Has health insurance 421 71 167 80 .02
Health insurance
Government sponsored 288 69 103 62 .01
Employment sponsored/private  63 15 46 28
Other 67 16 17 10 
Receives routine medical care 416 70 174 83 .01
Location of routine medical care
Hospital clinic/health center 333 80 127 73 .13
Private doctor 65 16 39 22
Otherb 18 4 8 5 
Received health/social services from  
a government or community agency  
high risk group c 379 64 133 64 .90
aNon-shortage period was February–April 2004 and shortage period was October–December 2004.
bOther self-reported sources of care were emergency departments and methadone programs. 
cPeople 65 years of age and older, adults 18 years of age and older who have heart disease, kidney 
disease, diabetes, HIV/AIDS, asthma, and other chronic diseases.
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had private health insurance more often (28% vs. 15%). Using the CDC’s criteria for 
immunizing high-risk groups, 48% (n281) of participants in the non-shortage period 
and 40% (n85) of participants in the shortage period met eligibility for influenza 
vaccination. All values were significant at the p.10 level. 
A total of 183 (31% of) people in the non-shortage period reported receiving the 
influenza vaccine during the non-shortage season, of whom 57% (n105) were in a 
high-risk group. In the shortage period, while 52% of people tried to obtain the influ-
enza vaccine, only 18% (n38) of participants were successful, of whom 68% (n26) 
were in a high-risk group. 
Unadjusted and adjusted associations with receipt of influenza vaccination during 
the non-shortage period are shown in Table 2. Individuals who were vaccinated were 
more likely to be older, to have been homeless, to have injected or used illegal drugs, 
to have health insurance, to have accessed routine medical care, to have received health 
or social services from a government or community agency, and to be a member of a 
high-risk group. After multivariate adjustment, a positive association remained between 
receipt of vaccination and older age (OR 1.02; 95% CI 1.01–1.04), having health insur-
ance (OR 2.36; 95% CI 1.36–4.12), receiving routine medical care at a hospital based 
clinic or health center (OR 2.79, 95% CI 1.61–4.81) or from another source of care 
(such as a methadone program) (OR 6.01; 95% CI 2.00–18.07), and having had an 
HIV test, whether the results were negative (OR 1.97; 95% CI 1.15–3.35) or positive 
(OR 13.86; 95% CI 4.26–44.08). 
Unadjusted and adjusted associations with receipt of influenza vaccination during 
the shortage period of 2004–2005 appear in Table 3. While older age was again a sig-
nificant correlate in bivariate analysis we found that men (OR 4.16; 95% CI 1.95–8.87) 
and those in a high-risk group (OR 4.15; 95% CI 1.95–8.81) were almost four times 
more likely to have been vaccinated than their counterparts. Blacks (OR 0.21; 95% 
table 2. 
faCtorS aSSoCIated wIth INflUeNza VaCCINatIoN 
dUrINg the 2003–2004 NoN-Shortage SeaSoN
 Unadjusted odds   adjusted odds 
Variable ratio (95% CI) p-value ratio (95% CI)
Age 1.02 (1.01–1.03) .01 1.02 (1.01–1.04)
Gender 
Female Reference
Male .91 (.64–1.29) .59
Race/ethnicity 
Caucasian/other  Reference
Hispanic 1.54 (.74–3.20) .25
Black  1.73 (.76–3.92) .19
(Continued on p. 617)
617Phillips-Caesar, Coady, Blaney, Ompad, Sisco. Glidden, Vlahov, and Galea
table 2 (continued).
 Unadjusted odds   adjusted odds 
Variable ratio (95% CI) p-value ratio (95% CI)
Income 
$9,600/year or less Reference
$9,601/year or more 1.02 (.68–1.54) .91
History of homelessness 
No Reference
Yes 1.83 (1.28–2.61) .01 1.20 (.78–1.85)
Hungry in the past 6 months 
No Reference
Yes .84 (.57–1.25) .40
History of injection drug use 
No Reference
Yes 2.80 (1.71–4.58) .01 1.72 (.93–3.16)
History of illegal drug use 
No Reference 
Yes 1.74 (1.22–2.47) .01 
History of trading sex for money
No Reference
Yes 1.33 (.67–2.64) .41
Has health insurance 
No Reference
Yes 3.48 (2.18–5.56) .01 2.36 (1.36–4.12)
Type of health insurance
Government sponsored Reference
Employer sponsored/private .74 (.42–1.32) .31
Other .68 (.38–1.19) .18
Receives routine medical care & location of care 
No routine care Reference
Hospital clinic/health center 4.18 (2.58–6.78) .01 2.79 (1.61–4.81)
Private doctor 2.05 (1.01–4.18) .05 1.58 (.72–3.45)
Other  7.86 (2.82–21.91) .01 6.01 (2.00–18.07)
HIV status
Never tested Reference
Negative 2.10 (1.35–3.27) .01 1.97 (1.15–3.35)
Positive 17.16 (5.98–49.29) .01 13.86 (4.26–45.08)
Received health or social services from a government or community agency
No Reference
Yes 1.63 (1.11–2.37) .01 .91 (.58–1.44)
High-risk group 
No Reference
Yes 1.77 (1.25–2.52) .01 .98 (.65–1.49)
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CI 0.05–0.86) were less likely to have been vaccinated than their counterparts. These 
same factors remained statistically significant after multivariate adjustment. 
discussion
We found low rates of vaccination during non-shortage periods, in particular among 
high-risk groups younger than 65 years of age. During the 2003–2004 influenza sea-
son, only 31% of our participants reported receiving the influenza vaccine, of whom 
approximately half were members of a high-risk group. These rates are comparable to 
New York City data from 2002, which showed 31% of adults 50–64 years of age, and 
approximately 35% of people with chronic health conditions, reported receiving the 
influenza vaccine.11 Low vaccination coverage among minorities and people living in 
and near poverty is a persistent problem.12 Immunization rates correlate with a number 
of factors, including demographic characteristics, attitudes about vaccination, trust in 
the health care system, health norms, and barriers to access (including income and 
immunization delivery methods).13–15 Issues of trust was evident in one of our earlier 
papers where 19% of participants reported that the vaccine shortage was due to the 
government not wanting to make the vaccine available.16 During the non-shortage period 
we found that participants who had health insurance and received routine medical care 
were more likely to be vaccinated. Interestingly, non-traditional sources of health care 
such as methadone programs and/or being tested for HIV were also associated with 
being vaccinated. These findings support calls to strengthen and expand access to risk 
reduction programs for marginalized groups. These programs represent an important 
opportunity for the provision of broader preventive health services. 
During the subsequent vaccine season, we observed even lower rates of vaccination. 
Although 64% of high-risk people tried to get the vaccine, only 18% of them were suc-
cessful in being vaccinated. This low vaccination rate persisted in our study neighbor-
hoods even when vaccine was more readily available in the later part of the influenza 
season. During phase III, from January–March 2005, we vaccinated 566 people in 4 
of the 8 study neighborhoods. Of the 510 people with available data, only 25 (5%) had 
been vaccinated in the past year. Furthermore, participants who were Black were less 
likely to be vaccinated and those with health insurance or access to routine medical 
care were not more likely to be vaccinated during this period.
Several of our findings are consistent with national influenza immunization data. 
Data from the Behavioral Risk Factor Surveillance System demonstrated that among 
adults aged 65 years or older in designated priority groups for vaccination, race/ethnicity 
significantly affected coverage both during the shortage and thereafter. In November 
2004, the odds that Blacks had been vaccinated were 63% lower than the odds for 
Whites, while the odds for Hispanics and Whites did not differ statistically. Although 
there was no racial difference in vaccination rates among vaccine-priority adults aged 
18–64 years (29% for Whites, 22% for Blacks, and 23% for Hispanics) the overall vac-
cination rates were quite low.17 
Low immunization rates among high-risk, younger people may be due to several 
factors. First, the primary use of the influenza vaccine has been to reduce morbidity 
and mortality among adults 65 years old and older and children ages 6 to 23 months.18,19 
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table 3. 
faCtorS aSSoCIated wIth INflUeNza VaCCINatIoN 
dUrINg the 2004–2005 Shortage SeaSoN
 Unadjusted odds   adjusted odds 
Variable ratio (95% CI) p-value ratio (95% CI)
Age 1.05 (1.02–1.09) .01 1.05 (1.02–1.09)
Gender 
Female Reference
Male 4.16 (1.95–8.87) .01 3.42 (1.38–8.46)
Race/ethnicity 
Caucasian/other  Reference
Hispanic .49 (.16–1.55) .23 .47 (.11–1.92)
Black  .21 (.05–.86) .03 .12 (.02–.64)
Income 
$9,600/year or less Reference
$9,601/year or more 1.16 (.56–2.38) .70
History of homelessness 
No Reference
Yes 1.43 (.66–3.08) .36
Hungry in the past 6 months 
No Reference
Yes .83 (.27–2.56) .74
History of injection drug use 
No Reference
Yes 2.02 (.67–6.12) .21 
History of illegal drug use 
No Reference 
Yes 1.37 (.67–2.78) .39 
History of trading sex for money
No Reference
Yes .40 (.05–3.16) .38
Has health insurance 
No Reference
Yes 1.46 (.57–3.76) .43
Type of health insurance
Government sponsored Reference
Employer sponsored/private .95 (.40–2.27) .91
Other .52 (.11–2.46) .41
(Continued on p. 620)
620 Influenza vaccination during a national shortage
Second, there is still a lack of awareness of the need for vaccination among adults younger 
than 65 years with high-risk conditions, such as diabetes or asthma. In a 2003 survey, 
approximately 75% of unvaccinated people aged 18–64 years with diabetes reported 
that they were unaware of the need for influenza vaccine.20 Third, targeting adults for 
vaccination by high-risk conditions has proven to be more challenging than targeting 
adults based on age.21 Together, these factors have resulted in a significant percentage 
of the at risk population between the ages of 18–64 years remaining unvaccinated. 
Among this group we found a high rate (61%) of willingness to be vaccinated during 
the shortage. High-risk younger adults may be very receptive to receiving vaccination 
when awareness of the benefits of vaccination is high (as it was during the shortage). 
Interestingly this willingness did not translate into similar vaccination rates during 
the shortage period. Although more participants in the shortage period had access 
to health care, only 18% of participants were successful in being vaccinated. We also 
found that the location of care differed during the two periods. While in both periods 
individuals who used other sources of care (i.e., methadone programs) were more likely 
to be vaccinated, during the shortage those who used a private doctor were more likely 
to be vaccinated than their counterparts who used a hospital-based clinic or health 
center. This may in part be explained by the lack of a national mechanism to distribute 
the flu vaccine equally among high-risk individuals when supply is limited.22 Influenza 
table 3 (continued).
 Unadjusted odds   adjusted odds 
Variable ratio (95% CI) p-value ratio (95% CI)
Receives routine medical care &  
location of care 
No routine care Reference
Hospital clinic/health center 3.18 (.71–14.30) .13 2.70 (.55–13.23)
Private doctor 7.56 (1.56–36.68) .01 5.08 (.93–27.84)
Other  17.00(2.33–124.19) .01 8.31 (.87–79.12)
HIV status
Never tested Reference
Negative 3.41 (.77–15.04) .11 3.75 (.64–21.92)
Positive 8.29 (1.26–54.71) .03 3.58 (.37–34.53)
Received health or social services  
from a government or  
community agency
No Reference
Yes 1.30 (.61–2.75) .50 
High-risk group 
No Reference
Yes 4.15 (1.95–8.81) .01 2.79 (1.16–6.73)
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vaccine is distributed largely through multiple channels in the private sector that have 
evolved to meet the specific needs of different types of purchasers. A relatively small 
amount of vaccine is purchased and distributed by the CDC or by state and local health 
departments.23 As a result, during the last vaccine shortage seasons (2001 and 2004) 
some providers received limited or no supplies of vaccine while other providers received 
full allotments. In some cases, community- or work-site-based clinics and large store 
chains received vaccine before physician offices, hospitals, and nursing homes.24 These 
findings suggest an urgent need for the development of a national system to ensure 
equal and appropriate distribution of vaccine to high-risk groups, particularly when 
vaccines are in short supply. 
Our study had several limitations. First, we relied on self-report of interest in vac-
cination, which may not translate into future seeking out of vaccination. However, 
mitigating this concern, prior studies have shown that self-report of influenza vacci-
nation is reliable.25–27 Second, this intervention took place in eight small underserved 
neighborhoods in NYC; it is difficult to know the extent to which these findings are 
generalizable to other populations in other areas. Third, over the course of the sur-
vey there was a notable seasonal difference in the number of participants recruited. 
Respondents may have visited a venue more than once and thus have multiple chances 
of selection. Fourth, while this work was informed by an active community participa-
tory process that served to inform all aspects of the intervention, future inquiry into 
the determinants of vaccination during times of shortage may benefit from qualitative 
research that may deepen our understanding of why people did or did not get vac-
cinated. Finally, it is difficult to say if people who agreed to be surveyed differed from 
those who refused. However, our methods have been validated in other studies28 and 
therefore we believe our results stand.
Conclusion
Recent studies suggest that the most effective way to minimize influenza-related 
morbidity and mortality is not only to vaccinate high-risk groups but also those at 
high-risk of transmitting influenza.29–32 This is of vital importance during a time of 
national preparedness efforts against a future influenza pandemic. Prior infectious 
disease epidemics have demonstrated that populations with low vaccination coverage 
are a source for continued spread of disease. During the last smallpox epidemic in the 
U.S. (Boston 1901–1903), it was only after the implementation of a door-to-door vac-
cine program and forced vaccination of the homeless that public health officials began 
to see a steady decline of cases and the end of the epidemic.33 Thus, gaining access to 
members of HTR populations may be key to the success of population-wide vaccination 
efforts. Our study represents an important step in utilizing non-traditional strategies 
to address this gap in the health care system. 
Given the central role played by individual health care providers and community-
based organizations in delivering vaccines both during shortage and during other 
periods, these providers may be central to any effort that aims to address the barriers 
to immunization faced by HTR populations. Interventions that maximize the reach 
and potential of these organizations may hold promise for increasing vaccination rates 
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in HTR populations nationwide. This may be particularly important in an era of vac-
cination shortages and pandemic preparedness where it is necessary to improve our 
ability efficiently to deliver vaccine to people who are not only at high risk but who 
may harbor the disease.
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